Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-Tooth disease type 1B

Neuromuscul Disord. 2006 Mar;16(3):183-7. doi: 10.1016/j.nmd.2006.01.006. Epub 2006 Feb 20.

Abstract

Autosomal dominant Charcot-Marie-Tooth disease type 1B (CMT1B) is caused by heterozygous mutations in the extracellular domain of P0. Here, we investigated clinically, electrophysiologically and pathologically a pedigree with a novel mutation in the intracellular domain of P0 (P0ic). The mutational analysis included denaturing high performance liquid chromatography (DHPLC) and nucleotide sequencing. Two patients from subsequent generations were homozygous for an Asp195Tyr mutation in the intracellular domain of P0 (P0ic), whereas two healthy individuals with minimal electrophysiological changes were heterozygous for the same mutation. The authors conclude that mutations of P0ic may undergo a gene dosage effect manifesting semidominant inheritance.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aspartic Acid / genetics
  • Charcot-Marie-Tooth Disease / genetics*
  • Charcot-Marie-Tooth Disease / pathology
  • Charcot-Marie-Tooth Disease / physiopathology
  • Chromatography, High Pressure Liquid / methods
  • DNA Mutational Analysis / methods
  • Exons
  • Family Health
  • Female
  • Gene Dosage*
  • Humans
  • Male
  • Microscopy, Electron, Transmission / methods
  • Molecular Sequence Data
  • Mutation*
  • Myelin P0 Protein / genetics*
  • Nerve Fibers, Myelinated / pathology
  • Nerve Fibers, Myelinated / ultrastructure
  • Pedigree
  • Protein Structure, Tertiary / genetics
  • Tyrosine / genetics

Substances

  • Myelin P0 Protein
  • Aspartic Acid
  • Tyrosine